News - Takeda Pharmaceuticals, Financial

Filter

Popular Filters

Takeda's lymphoma drug Adcetris approved in Japan

Takeda's lymphoma drug Adcetris approved in Japan

18-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical has received approval from the country’s Ministry…

AdcetrisFinancialOncologyPharmaceuticalRegulationSeattle GeneticsTakeda Pharmaceuticals

Takeda Pharma six-month profits down, despite sales growth

Takeda Pharma six-month profits down, despite sales growth

01-11-2013

Takeda Pharmaceuticals, Japan’s largest drugmaker, this morning posted financial results for the six…

FinancialPharmaceuticalTakeda Pharmaceuticals

Takeda partners with newly-formed Tri-1 TDI

Takeda partners with newly-formed Tri-1 TDI

07-10-2013

The USA’s Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical…

Asia-PacificFinancialNorth AmericaPharmaceuticalResearchTakeda Pharmaceuticals

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

05-10-2013

The Russian Yaroslavl region is expected to become one of the major centers of the country’s pharmaceutical…

AbbVieCadila PharmaceuticalsEuropeFinancialPharmaceuticalProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

Top-line financials for Japanese drug majors

01-08-2013

Among a flurry of first-quarter fiscal 2013/14 financial results released by Japanese drug majors, the…

Dainippon Sumitomo PharmaEisaiFinancialMitsubishi TanabePharmaceuticalTakeda Pharmaceuticals

Evolution of Japan's pharma wholesalers - by P Reed Maurer

03-07-2013

Half of the definition for evolution (noun; a gradual process in which something changes especially into…

Asia-PacificFinancialMitsubishi TanabePharmaceuticalProductionSankyoShionogiTakeda Pharmaceuticals

$10 million milestone for Sucampo, as Takeda starts US selling of Amitiza for OIC

27-06-2013

USA-based Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a $10 million milestone payment…

AmitizaFinancialGastro-intestinalsMarkets & MarketingNorth AmericaPharmaceuticalSucampoTakeda Pharmaceuticals

Top-line financial results from Japanese drug majors

09-05-2013

Among a batch of Japanese drug majors presenting fiscal year 2013 (ended April 2013) financial results,…

Dainippon Sumitomo PharmaFinancialMitsubishi TanabePharmaceuticalShionogiTakeda Pharmaceuticals

MHLW joins Japan's first P-PP to facilitate R&D of new health technologies for the developing world

08-04-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) has said it supports the research and development…

Asia-PacificAstellas PharmaDaiichi SankyoEisaiFinancialHealthcarePharmaceuticalResearchShionogiTakeda PharmaceuticalsTropical diseases

Takeda, Shionogi, Ono Pharma and Mitsubishi Tanabe post nine-month results

04-02-2013

Takeda Pharmaceuticals (TYO: 4502), Japan's largest drugmaker, has reported nine-month 2013 results with…

FinancialMitsubishi TanabeOno PharmaceuticalPharmaceuticalShionogiTakeda Pharmaceuticals

Infinity amends PI3K-delta, gamma accord with Millennium

28-12-2012

US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) says it has amended its development and…

BiotechnologyFinancialInfinity PharmaceuticalsIPI-145LicensingMillennium PharmaceuticalsPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

Takeda's leadership as Japan's largest drugmaker set to decline, says DR

29-10-2012

Based on full-year 2011 sales, Japan's Takeda Pharmaceutical (TYO: 4502) maintained its position as the…

Asia-PacificAstellas PharmaFinancialPharmaceuticalResearchTakeda Pharmaceuticals

Japan's drug majors post mixed financial results

31-07-2012

Japan's leading drugmakers rolled out financial results for the first fiscal quarter of 2013, ended June…

Daiichi SankyoDainippon Sumitomo PharmaFinancialKyowa Hakko KirinPharmaceuticalTakeda Pharmaceuticals

Takeda completes URL acquisition which will immediately boost revenues

06-06-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) said yesterday that it has now completed…

ColcrysFinancialMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsURL Pharma

Takeda posts downturn in sales for FY 2012; forecasts operating profit slump

15-05-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) posted disappointing results for its fiscal…

FinancialPharmaceuticalTakeda Pharmaceuticals

Costs take toll on earnings from Japan’s Takeda

01-02-2012

Japan’s largest drugmaker, Takeda Pharmaceutical (TSE: 4502), yesterday released consolidated results…

FinancialNycomedPharmaceuticalTakeda Pharmaceuticals

Takeda cuts 2,800 jobs as it assimilates Nycomed

19-01-2012

Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Takeda slashes full-year forecasts on Nycomed costs and yen strength

07-11-2011

Takeda Pharmaceuticals (TYO: 4502), Japan’s largest drugmaker, posted flat results for the fiscal…

FinancialPharmaceuticalTakeda Pharmaceuticals

Sanofi to top Pfizer as number one for global pharma sales

01-11-2011

French drug major Sanofi (Euronext: SAN) is expected to take the top spot amongst the world’s pharmaceuticals…

FinancialGlobalJohnson & JohnsonMarkets & MarketingMerck & CoMergers & AcquisitionsNovartisNovo NordiskPfizerPharmaceuticalSanofiTakeda PharmaceuticalsTeva Pharmaceutical Industries

Takeda and Daiichi Sankyo both get Japanese government grants for vaccine facilities

23-08-2011

Japan’s largest drug company Takeda Pharmaceuticals (TYO: 4502) and fellow major Daiichi Sankyo…

Anti-viralsAsia-PacificBaxter InternationalDaiichi SankyoFinancialPharmaceuticalTakeda Pharmaceuticals

Affymax gets $10 million milestone from Takeda on peginesatide NDA acceptance

11-08-2011

California, USA-based Affymax (Nasdaq: AFFY) says it has received a $10 million development milestone…

AffymaxFinancialHematideOncologypeginesatidePharmaceuticalRegulationTakeda Pharmaceuticals

First-quarter FY 2012 net profit at Takeda jumps 18%, while that at Daiichi Sankyo slumps 23.5%

02-08-2011

There were mixed financial reports from Japanese drugmakers, with the country’s biggest, Takeda…

Daiichi SankyoFinancialPharmaceuticalRanbaxy LaboratoriesTakeda Pharmaceuticals

Back to top